Workflow
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update
Globenewswire· 2026-02-05 21:05
NOVATO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Thursday, February 12, 2026, to discuss its financial results and corporate update for the quarter and the year ending December 31, 2025. The live and replayed webcast of the call will be available t ...
Exponent Increases Quarterly Dividend Payment from $0.30 to $0.31 per Share for Q1 2026
Globenewswire· 2026-02-05 21:05
MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly cash dividend from $0.30 to $0.31 per share of common stock. The quarterly cash dividend of $0.31 per share of common stock is to be paid on March 20, 2026 to all common stockholders of record as of March 6, 2026. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of ...
Hub Group Reports Select Preliminary Fourth Quarter and Full Year 2025 Results
Globenewswire· 2026-02-05 21:05
Company delays full earnings release and conference callHighlights: Fourth quarter intermodal volume increased 1% from prior yearStrong year-end balance sheet with cash and restricted cash of approximately $140 million and lower net debt2025 preliminary operating cash flow of approximately $194 million2025 capital expenditures of approximately $45 million Introduced preliminary 2026 outlook with expected revenue of $3.65 billion to $3.95 billion and capital expenditures of $35 million to $45 million OAK B ...
Amwell® to report fourth quarter and full year 2025 operating results
Globenewswire· 2026-02-05 21:05
BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report fourth quarter and full year 2025 operating results after stock market trading hours on Thursday, Feb. 12. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business u ...
LiveRamp Announces Results for Third Quarter FY26
Globenewswire· 2026-02-05 21:05
Core Insights - LiveRamp reported a 9% year-over-year increase in total revenue for the quarter ended December 31, 2025, reaching $212 million [7][6] - The company achieved record quarterly operating margin and operating cash flow, with operating income rising to $40 million from $15 million in the prior year [5][7] - Share repurchases totaled $119 million fiscal year-to-date, with 1.4 million shares repurchased in the third quarter [7][6] Financial Performance - Subscription revenue was $158 million, up 9% year-over-year, while Marketplace & Other revenue increased by 8% to $54 million [7][6] - GAAP gross profit was $153 million, reflecting a 9% increase, with a gross margin of 72% [7][6] - Non-GAAP operating income rose by 36% to $62 million, with a non-GAAP operating margin of 29% [7][6] Earnings and Cash Flow - Net earnings for the quarter were $40 million, compared to $11 million in the prior year, resulting in diluted earnings per share of $0.62 [7][6] - Operating cash flow increased to $67 million from $45 million year-over-year [7][6] - Free cash flow for the quarter was also reported at $67 million, up from $45 million [8] Business Developments - The company launched new AI tools in its Data Marketplace and expanded partnerships, notably with Publicis [5][12] - LiveRamp ended the quarter with 140 customers generating over $1 million in annualized subscription revenue, an increase from 125 in the previous year [12][7] - Annualized recurring revenue (ARR) reached $527 million, up 7% compared to the prior year [12][7]
Pool Corporation Announces Year End and Fourth Quarter 2025 Earnings Release Date and Conference Call
Globenewswire· 2026-02-05 21:05
COVINGTON, La., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq: POOL) announced today that the Company will release its full year and fourth quarter 2025 earnings results before the market opens on February 19, 2026, and will hold a conference call to discuss the results at 10:00 a.m. Central Time (11:00 a.m. Eastern Time) that same day. The earnings release as well as a live webcast and replay of the conference call will be available on the Company’s website at www.poolcorp.com. The conference ...
StepStone Group Reports Third Quarter Fiscal Year 2026 Results
Globenewswire· 2026-02-05 21:05
NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP), a global private markets investment firm focused on providing customized investment solutions and advisory and data services, today reported results for the quarter ended December 31, 2025. This represents results for the third quarter of the fiscal year ending March 31, 2026. The Board of Directors of the Company has declared a quarterly cash dividend of $0.28 per share of Class A common stock, payable on March 13, 2026, to th ...
California Water Service Group Schedules 2025 Full-Year and Fourth-Quarter Earnings Results Announcement and Conference Call
Globenewswire· 2026-02-05 21:05
SAN JOSE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- California Water Service Group (NYSE: CWT) today announced that its 2025 full-year and fourth-quarter earnings results will be released after market-close on Wednesday, February 25, 2026, and its earnings conference call will be held at 11:00 a.m. ET on Thursday, February 26, 2026. All stockholders and interested investors are invited to attend the conference call. To attend, please dial 1-800-715-9871 or 1-646-307-1963 and key in ID# 2201083, or you may a ...
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
Globenewswire· 2026-02-05 21:05
SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the fourth quarter and full year ended December 31, 2025. “2025 was an outstanding year for Adaptive, marked by strong execution and meaningful progress across the business,” said Chad Robi ...
Viasat Releases Third Quarter Fiscal Year 2026 Financial Results
Globenewswire· 2026-02-05 21:05
CARLSBAD, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today published its third quarter fiscal year 2026 financial results. The letter to shareholders and accompanying webcast slides are available on the Investor Relations section of the company's website. Conference Call DetailsAs previously announced, Management will host a conference call to discuss the results today, Thursday, February 5, 2026 at 2:30 p.m. PT (5:30 p.m. ET). Access ...